Abiopharma

New Form SCHEDULE 13G/A - Tarsus Pharmaceuticals, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001137774-26-000101 <b>Size:</b> 7 KB

(80% Positive) CYCURION, INC. (CYCUW) Announces Business Combination

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001140361-26-019864 <b>Size:</b> 355 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001140361-26-019863 <b>Size:</b> 324 KB

New Form FWP - MORGAN STANLEY <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001839882-26-023379 <b>Size:</b> 101 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-213842 <b>Size:</b> 517 KB

Myseum.AI to Present at 16th Annual LD Micro Invitational Conference; Picture Party Named Official Private Social Media Platform

Net Asset Value(s)

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

Antelope Enterprise Holdings Limited Announces $190,000 in Realized Gains from its “Genius Plan” and Authorizes an $95,000 Share Repurchase Program, Validating its Sustainable Capital Recycling Framework

(85% Positive) MCEWEN INC. (MUX) Reports Q2 2026 Financial Results

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001839882-26-023377 <b>Size:</b> 405 KB

New Form SCHEDULE 13G/A - Veris Residential, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001137774-26-000100 <b>Size:</b> 7 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001213900-26-053659 <b>Size:</b> 273 KB

InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares